Rapidly growing pharmaceutical services platform welcomes long-time industry executive as Senior Advisor, expanding leadership role beyond Board of Directors NASHVILLE, Tenn (March 5, 2025)—Petauri, a leading purpose-built pharmaceutical services platform, is pleased to announce that William Fleming, PharmD, has expanded his role within the company, joining as a Senior Advisor in addition to continuing as…
Rapidly growing pharmaceutical services platform bolsters pricing and market access consulting arm with addition of channel strategy offering. NASHVILLE, Tenn (February 12, 2025)—Petauri, a leading purpose-built pharmaceutical services platform, announced today the launch of its new channel strategy offering. This expanded service will be part of the organization’s consulting arm, Petauri Advisors, which focuses on…
Rapidly growing pharmaceutical services platform continues to expand team with experienced business development executive. NASHVILLE, Tenn (January 23, 2025) — Petauri, a leading purpose-built pharmaceutical services platform, today announced the appointment of Mark Levonyak as Executive Vice President of New Business for Petauri Advance, the organization’s scientific and medical communications business unit. In this role,…
Rapidly growing pharmaceutical services provider announces the formation of its internal collective of former access decision-makers NASHVILLE, Tenn. (January 9, 2025) — Petauri, a leading purpose-built pharmaceutical services provider, announced today the launch of its Access Customer Experience (“ACE”) team, an internal collective of industry experts who provide unparalleled insights and strategies for market access….
Rapidly growing pharmaceutical services platform leadership recognized for making significant contributions to healthcare marketing and communications. NASHVILLE, Tenn. (December 11, 2024) — Petauri, a leading purpose-built pharmaceutical services platform, announced today that Nicole Lodowski, Managing Director of Petauri Evidence, has been recognized as one of MM+M’s esteemed 40 Under 40 honorees for 2025. Amanda Peterson,…
Rapidly growing pharmaceutical services platform expands leadership team to shape the future of its recently formed market access agency NASHVILLE, Tenn (12/4/2024) – Petauri, a leading purpose-built pharmaceutical services platform, is pleased to announce the appointments of Megan Jankura and Liz Lucas as co-leaders of Petauri MAx, reporting to Dan Vanderpoel, Managing Partner of Petauri MAx…
Rapidly growing pharmaceutical services platform bolsters pricing and market access offering, merging business with Petauri Advisors NASHVILLE, Tenn. (November 13, 2024) — Petauri, a leading purpose-built pharmaceutical services platform, announced today the acquisition of Formulary Insights, a trusted partner to pharmaceutical and life sciences clients for US market access insights and strategy. This strategic acquisition…
Rapidly growing pharmaceutical services provider responds to high growth areas with 2 new adjacent business units NASHVILLE, Tenn. (October 30, 2024) — Petauri, a leading purpose-built pharmaceutical services provider, announced today the renaming of one of its core units, The Kinetix Group, and the strategic decision to restructure it into 2 complementary units, Petauri Kinect…
Rapidly growing pharmaceutical services provider unites existing capabilities into a comprehensive Medical Communications platform NASHVILLE, Tenn. (October 8, 2024) — Petauri, a leading purpose-built pharmaceutical services provider, announced today the formation of Petauri Advance, a forward-thinking medical communications platform. This platform is designed to integrate and optimize healthcare communications for the life sciences industry, bridging…
Rapidly growing pharmaceutical services platform adds four world-class agencies from the Brightly Network
NASHVILLE, Tenn. (August 14, 2024) — Petauri, a leading purpose-built pharmaceutical services platform, announced today the acquisition of four US-based firms…
NEW YORK, July 23, 2024 — The Kinetix Group-Powered by Petauri™ (TKG) has been named a Market Access Agency of the Year finalist in the 2024 MM+M Awards.
The MM+M Awards recognizes, champions and celebrates creativity and effectiveness in healthcare marketing and communications.
“We have an incredible team at TKG who is truly passionate about empowering informed decision-making and access to patient care…
Rapidly growing pharmaceutical services platform continues to expand team with experienced business development executive
NASHVILLE, Tenn. (July 9, 2024) — Petauri, a leading purpose-built pharmaceutical services platform, announced the appointment of Hunter Clark to its business development team. In his role, Hunter will collaborate with Petauri’s growing team of commercialization experts to identify and secure new client partnerships across the biopharmaceutical services space.
Rapidly growing pharmaceutical services platform announces transformational expansion, acquiring two leading businesses focused on evidence-based value demonstration and global market access
NASHVILLE, Tenn. (June 18, 2024) — Petauri, a leading purpose-built pharmaceutical services platform, announced today the addition of two UK-based firms: Mtech Access, a premier full-service global market access solutions provider; and Delta Hat, an experience-led company specializing in the technical aspects of evidence-based value demonstration…
Rapidly growing pharmaceutical services platform announces the addition of accomplished executives devoted exclusively to innovative approaches to evidence generation and strategy
NASHVILLE, Tenn. (May 2, 2024) — Petauri, a leading purpose-built pharmaceutical services platform, announced today the addition of Nicole Lodowski and Bob Nordyke to lead a team dedicated to evidence generation and value strategy across the product lifecycle, from early pipeline evidence planning through post-launch evidence generation.
Rapidly growing pharmaceutical services platform continues to expand leadership team with highly experienced market access executives
NASHVILLE, Tenn. (April 29, 2024) — Petauri Advisors, a strategic life sciences consulting business unit of Petauri, a leading purpose-built pharmaceutical services platform, announced today that it has added to its executive ranks 2 experienced leaders who bring extensive market access experience and expertise comprising implementation of Medicare Part D, the Affordable Care Act, and brand marketing.
Rapidly growing pharmaceutical services platform continues to expand leadership team with highly experienced market access executive
NASHVILLE, Tenn. (April 2, 2024) — Petauri, a leading purpose-built pharmaceutical services platform, announced today that Dan Vanderpoel has joined the company in the dual role of Executive Vice President, Strategic Payer Marketing, and Head, Client Solutions.
MM+M has announced its 2024 Pinnacle Awards honorees, who hail from a diverse range of health- and wellness-adjacent organizations.
NASHVILLE, Tenn. (February 29, 2024) — Petauri is proud to announce that Dan Renick, CEO of Petauri, has been named as one of the esteemed honorees of the MM+M Pinnacle Awards 2024. This prestigious accolade recognizes exceptional marketers, strategists, and creators for their leadership, innovation, and contributions to the industry.
This prestigious recognition for FORCE Communications––Powered by Petauri™ underscores the company’s commitment to fostering a positive and rewarding work environment for its employees.
NASHVILLE, Tenn. (February 27, 2024) — FORCE Communications, a leading provider of innovative medical communication solutions, is proud to announce its recent accolade as one of the Best Places to Work in Indiana. This prestigious recognition underscores the company’s commitment to fostering a positive and rewarding work environment for its employees.
NASHVILLE, Tenn. (February 14, 2024) — Petauri, a purpose-built pharmaceutical services platform, announced its acquisition of FORCE Communications and its 3 independent companies, DRIVE, MOMENTUM, and PROPEL, which bring science to life on behalf of clients and their medical innovations.
